Moderate Exercise May Make Cancer Treatments More Effective, Kinesiologist Finds

Keep walking
Keep Walking
For cancer patients, a brisk walk or a slow jog on a regular basis may be the key to improved cancer treatments.

Brad Behnke, associate professor of exercise physiology at Kansas State University has shown together with colleagues that moderate exercise on a regular basis enhances tumor oxygenation. Getting more oxygen into a tumor may improve treatments in cancer patients. Continue reading Moderate Exercise May Make Cancer Treatments More Effective, Kinesiologist Finds

Targeting B Cells to Tackle Immune System Suppression in High Risk Prostate Cancers

In mouse models immune cell manipulation plus chemotherapy achieves prostate cancer remission where chemotherapy alone fails

Blocking or removing immune-suppressing cells , researchers at the University of California, San Diego School of Medicine have found, allows a special type of chemotherapy — and the immune cells it activates — to destroy prostate tumors.

This combination therapy, termed chemoimmunotherapy, achieved near complete remission in mouse models of advanced prostate cancer. Continue reading Targeting B Cells to Tackle Immune System Suppression in High Risk Prostate Cancers

Abiraterone rejection in Scotland must be overturned, Prostate Cancer advocate says

Advocating for advanced prostate cancer patients in Scotland, Alister Walker, Chairman and volunteer in Perth & Kinross Prostate Cancer Support Group, writes in today’s online issue of the Scottish newspaper The Herald:

“Last week we read the good news that Moderator-Designate of the General Assembly of the Church of Scotland, the Reverend Dr Angus Morrison, has overcome the disease (Church leader in cancer warning , The Herald, April 23). With prostate cancer so often being symptomless in its early stages he is right to urge other men to consider speaking to their GP about the disease. This is particularly important for men aged over 50, black men and men whose father or brother has had the disease – who are at a higher risk.

“Less encouraging is the news, also rightly highlighted in The Herald, that men with an incurable form of the disease are to be denied access to the life-prolonging and life-enhancing drug abiraterone before chemotherapy on NHS Scotland (‘Review decision to reject cancer treatment, says drugs firm’ The Herald, April 15). Continue reading Abiraterone rejection in Scotland must be overturned, Prostate Cancer advocate says

Obama Proposes That Medicare Be Given the Right to Negotiate the Cost of Drugs

President Obama is proposing “a major new initiative to develop drugs tailored to the genetic characteristics of individual patients, but he expresses deep concern about the costs of such specialty medicines for consumers and for the Medicare program,” reports Robert Pear in April 27 New York Times. Continue reading Obama Proposes That Medicare Be Given the Right to Negotiate the Cost of Drugs

A Step Toward Personalized Chemotherapy

Implantable device could allow doctors to test cancer drugs in patients before prescribing

PSA Rising– April 24, 2015,   More than 100 drugs have been approved in the USA to treat cancer, but predicting which ones will help an individual patient is an inexact science. Patients may undergo weeks of noxious side effects before scans reveal that for this patient a particular drug is not working–even though it  works for the patient in the next chair. A new implantable device, about the size of a grain of rice, may change that. Continue reading A Step Toward Personalized Chemotherapy

Loss of WAVE1 gene linked to lethal prostate cancer


Dr Leszek Kotula, co-author of the WAVE1 study, explains in this video from 2013  how basic science research in his lab at Upstate Medical University in Syracuse, NY will benefit prostate cancer patients with better diagnostic and treatment options.


April 7, 2015. Researchers at Upstate Medical University, NY and Harvard University have linked the loss of key gene, WAVE1, to a lethal form of prostate cancer. They found that  in patients who were treated for prostate cancer, alterations in the WAVE1 gene were associated with a shorter remission.

Continue reading Loss of WAVE1 gene linked to lethal prostate cancer

Prostate Cancer Survivor News, info, Support